Dec 19, 2023 | Diane Hunter, SGL Blogs
The 65th American Society of Hematology (ASH) Annual Meeting & Exposition provided an increased number of abstract presentations from previous years on the topic of DEI and disparity. There is a need for clinical trial patient participation to be reflective of the...
Dec 19, 2023 | Oya Gilbert, SGL Blogs
I learned that your voice does matter after watching attendees ask questions — some simple, others not so much — but they were heard. I got overloaded with abstract presentations galore but absorbed the portion I needed most. I had conversations with scientists to...
Dec 18, 2023 | SGL Blogs, Sheri Baker
The 65th American Society of Hematology (ASH) annual conference has come and gone. I look forward to this each year, and so much preparation is done by staff at the International Myeloma Foundation (IMF) to help our Support Group Leader (SGL) team be ready for the...
Dec 18, 2023 | Michael Tuohy, SGL Blogs
To wrap up my #IMFASH23 experience, I’ll keep it simple and share with you this video that Teresa Miceli and I did at ASH discussing T-Cell redirecting therapy, CAR-T, bi-specifics and comparison of side effects of CAR-T to bi-specifics and different targets (did I...
Dec 18, 2023 | SGL Blogs, Teresa Miceli
We have reached the end of the annual meeting and exposition of the American Society of Hematology (ASH23). The time between the early mornings and late evenings were filled with oral and poster sessions, education programs, and connecting with members of the multiple...
Dec 18, 2023 | Robin Tuohy, SGL Blogs
In my last blog for #IMFASH23, I’ve decided to share a few of the videos and photos I took over the last week providing you with a variety of experiences, perspectives, and my “bird’s eye view” of leaders engaged at #ASH23. Leaders were “flies on the wall” to...
